LifeMD Net Income From Continuing Ops from 2010 to 2026
| LFMD Stock | USD 3.14 0.37 13.36% |
Net Loss | First Reported 2019-12-31 | Previous Quarter -1.6 M | Current Value -3.6 M | Quarterly Volatility 8.1 M |
Check LifeMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.5 M, Interest Expense of 2.6 M or Selling General Administrative of 87.7 M, as well as many indicators such as Price To Sales Ratio of 1.05, Dividend Yield of 0.0138 or Days Sales Outstanding of 22.78. LifeMD financial statements analysis is a perfect complement when working with LifeMD Valuation or Volatility modules.
LifeMD | Net Income From Continuing Ops | Build AI portfolio with LifeMD Stock |
Analyzing LifeMD's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing LifeMD's current valuation and future prospects.
Latest LifeMD's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of LifeMD Inc over the last few years. It is LifeMD's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LifeMD's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
LifeMD Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (15,351,763) | |
| Coefficient Of Variation | (137.26) | |
| Mean Deviation | 16,339,022 | |
| Median | (1,360,089) | |
| Standard Deviation | 21,072,091 | |
| Sample Variance | 444T | |
| Range | 60.1M | |
| R-Value | (0.56) | |
| Mean Square Error | 326.9T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | (2,322,738) | |
| Total Sum of Squares | 7104.5T |
LifeMD Net Income From Continuing Ops History
About LifeMD Financial Statements
LifeMD stakeholders use historical fundamental indicators, such as LifeMD's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although LifeMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in LifeMD's assets and liabilities are reflected in the revenues and expenses on LifeMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LifeMD Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -16.9 M | -17.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out the analysis of LifeMD Correlation against competitors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Health Care Equipment & Supplies sector continue expanding? Could LifeMD diversify its offerings? Factors like these will boost the valuation of LifeMD. Expected growth trajectory for LifeMD significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every LifeMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets | Return On Equity |
LifeMD Inc's market price often diverges from its book value, the accounting figure shown on LifeMD's balance sheet. Smart investors calculate LifeMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since LifeMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that LifeMD's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LifeMD represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.